logo
logo
Sign in

Global CRISPR Gene Editing Market

avatar
bisresearch reports
Global CRISPR Gene Editing Market

The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineering. However, there are several limitations, which need consideration before clinical applications.

Further, many researchers are working on the limitations of CRISPR gene editing technology for better results. The potential of CRISPR gene editing to alter the human genome and modify the disease conditions is incredible but exists with ethical and social concerns. The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.

Market Segmentation

• Product Type – CRISPR Products: Kits and Enzymes (Vector-Based Cas9, and DNA-Free Cas9), Libraries, Design Tools, Antibodies, and Other Products (CRISPR/Cas9 plasmids, CRISPR Controls, and CRISPR RNAs); CRISPR Services: gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, and Other Services (Mediated Transcriptome Editing, and Epigenome Editing Services)

• Application – Agricultural, Biomedical (Gene Therapy, Drug Discovery, And Diagnostics), Industrial, and Other Applications [Genetically Modified Foods (GM Foods), Biofuel, And Animal (Livestock) Breeding]

• End-User - Academic Institutes and Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), and Pharmaceutical and Biopharmaceutical Companies

Regional Segmentation

• North America – U.S., Canada

• Europe – Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of-Europe

• Asia-Pacific – China, Japan, India, South Korea, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)

• Latin America – Brazil, Mexico, and Rest-of-the-Latin America

• Rest-of-the-World

Growth Drivers

• Prevalence of Genetic Disorders and Use of Genome Editing

• Government and Private Funding

• Technology Advancement in CRISPR Gene Editing

Market Restraints

• CRISPR Gene Editing: Off Target Effects and Delivery

• Ethical Concerns and Implications with Respect to Human Genome Editing

Market Opportunities

• Expanding Gene and Cell Therapy Area

• CRISPR Gene Editing Scope in Agriculture

Key Companies Profiled

CRISPR Therapeutics, Horizon Discovery Group PLC, Cellecta, Inc., Integrated DNA Technologies, Inc., GenScript Biotech, ToolGen, Inc., System Biosciences LLC, Thermo Fisher Scientific, Inc., Origene Technologies, Inc., GeneCopoeia, Inc., New England Biolabs, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Abcam, Inc., Rockland Immunochemicals, Inc., Synthego Biosciences, Merck KGaA and Takara Bio

Furthermore, the companies are investing huge amounts in the research and development of CRISPR gene editing products, and gene therapies. The clinical trial landscape of various genetic and chronic diseases has been on the rise in recent years, and this will fuel the CRISPR gene editing market in the future.

Within the research report, the market is segmented based on product type, application, end-user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Get Sample Reporthttps://bisresearch.com/industry-report/crispr-gene-editing-market.html

 

 

 

collect
0
avatar
bisresearch reports
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more